In this photo illustration, a smartphone displays the logo of Oracle Corporation (NYSE: ORCL), an American technology company ...

Oracle (ORCL) is down sharply in 2026, but analysts stay bullish on cloud growth, backlog and upside potential.

William Blair adds Oracle, ServiceTitan, Everpure and Dynatrace to its Conviction List—AI cloud buildout, durable growth and ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Oracle carried out layoffs in March. A new filing shows how much smaller the workforce is compared to this time last year.

Recursion Pharmaceuticals is trying to solve a serious problem. Even with technological improvements, the time and costs required to develop brand-new drugs have increased in recent decades. It can ...

NAIC has confirmed it was targeted in the recent hacking campaign that exploited an Oracle PeopleSoft zero-day vulnerability.

Recursion is building an industrialized engine for medicine. It operates among biotech stocks, selling access to its proprietary platform and pursuing joint development with major partners like Roche ...

Oracle is cutting roughly 500 jobs in Romania, a year after a similar local round, as its global AI-driven restructuring continues.

Oracle’s stock fell on Monday after the company disclosed that it cut about 21,000 jobs, or 13% of its workforce, in fiscal ...

Oracle has decreased its workforce by tens of thousands in the past year while spending $70 billion to fund its AI expansion. Oracle is spending big on artificial intelligence—to the tune of $70 ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...